Author | Cui Yuanwei Editor | Chen Junda
Xin Dongxi reported on November 11 that the IPO application of Shandong Qingdao-based semiconductor equipment manufacturer SRI-I was accepted by the Shanghai Stock Exchange (SSE) STAR Market on November 10.
Founded in 2018, SRI-I primarily engages in the R&D, production, and sales of front-end semiconductor process equipment. Its products include Atomic Layer Deposition (ALD) equipment and Ion Implantation (IMP) equipment, which are widely used in integrated circuits, third-generation semiconductors, new energy, optics, and component coating fields.
According to QYResearch data, in 2025, SRI-I's ALD equipment ranked third globally and first among domestic manufacturers in market share within the compound semiconductor field, with a market share of 12.01%; it ranked first globally in market share for display devices and scientific research fields. The company's clients cover semiconductor manufacturing, display panels, and equipment components. Currently, SRI-I's customers include well-known domestic enterprises such as Jiangsu-based 8-inch silicon-based gallium nitride IDM manufacturer Innoscience, global display panel leader BOE, and Liaoning-based precision components manufacturer for semiconductor equipment Fuchuang Precision. It also serves research institutions such as the Interuniversity Microelectronics Centre (IMEC) in Belgium, Tsinghua University, and Peking University. According to its official website, SRI-I has been recognized as a national-level Specialized, Refined, Differential, and Innovative "Little Giant" enterprise. Regarding fundraising use, SRI-I plans to raise CNY 2 billion, of which CNY 1 billion will be allocated to the advanced semiconductor equipment R&D and manufacturing center project, CNY 600 million to high-end semiconductor equipment R&D projects, and CNY 400 million to supplement working capital. The R&D projects will focus on ultra-high-energy ion implantation equipment, hydrogen and helium ion implantation equipment, ALD equipment for integrated circuits, and key components.
01.Three Consecutive Years of Losses; Ion Implantation Equipment Contributed Revenue for the First Time This Year
In 2023, 2024, 2025, and the first half of 2026, the company achieved revenues of approximately CNY 349 million, CNY 363 million, CNY 495 million, and CNY 190 million, respectively; net profits were approximately -CNY 304 million, -CNY 271 million, -CNY 267 million, and -CNY 231 million, respectively; and R&D expenses were CNY 145 million, CNY 193 million, CNY 233 million, and CNY 116 million, respectively.
SRI-I's revenue has maintained a growth trend over the past three years, but it has not yet escaped losses. In just six months this year, the loss has already approached the full-year loss level of 2025. The company attributes its lack of profitability to three main reasons: first, SRI-I's core business is still in the development stage, and revenue has not reached scale; second, the technical barriers for its main products, ALD and IMP equipment, are high, requiring time for R&D investment; third, the company conducts global operations with manufacturing centers in China and Finland, requiring upfront investment in talent team building, capacity construction, and supply chain localization verification. By business structure, the ALD equipment business has long been the revenue pillar for SRI-I. From 2023 to 2025, the revenue share of this business exceeded 84%, reaching 88.32% in 2025. The IMP equipment business contributed revenue for the first time in 2026, generating CNY 50.7535 million in the first half of 2026, accounting for 27.16% of the current period's main business revenue.
Although the IMP equipment business only generated revenue this year, its share of first-year revenue exceeded 25%, demonstrating strong growth potential. Compared with peer companies' asset scales as of the end of 2025 and their 2025 operating metrics, SRI-I still has significant room for improvement in total assets, revenue, and net profit. However, the company continues to maintain substantial R&D investment, with an R&D expense ratio of 47.08% in 2025, which is at a high level among peers.
In terms of profitability, SRI-I's gross margins in 2023, 2024, 2025, and the first half of 2026 were 33.98%, 41.43%, 39.02%, and 22.13%, respectively. Among them, the gross margin for spare parts and technical services was relatively higher.
Compared with peer companies, except for2025, SRI-I's main business gross margin during other reporting periods was lower than the industry average.
02.Deploying Spatial ALD Equipment for 12-Inch Wafers; 392 Authorized Patents Obtained
The ALD business is one of SRI-I's earlier established businesses and forms the important basis for its competitive advantage in global niche markets; the IMP business is a key direction for expansion in recent years, tasked with further entering the core front-end equipment market for integrated circuits. ALD technology primarily forms thin films layer by layer through self-limiting reactions of different precursor gases on material surfaces. Compared with traditional deposition processes, its advantages lie in precise control of film thickness and uniform coverage on complex three-dimensional structures, making it widely used in dielectric layer, passivation layer, and barrier layer deposition in semiconductor manufacturing. Currently, SRI-I's P800 model ALD equipment was delivered to a leading domestic semiconductor manufacturing customer in August 2025; additionally, the company is deploying spatial ALD equipment for 12-inch wafers, improving film deposition efficiency and process stability by optimizing gas delivery systems and reaction chamber designs.
Notably, SRI-I is recently expanding ALD technology from traditional semiconductor manufacturing to new display and optical fields such as MicroLED and AR optical waveguides. Currently, the company's 8-inch mass-production equipment for optical waveguides has been delivered to customers, while 12-inch equipment remains in the R&D verification stage. Ion implantation is a critical process in semiconductor manufacturing, primarily involving ionizing and accelerating elements such as boron, phosphorus, and arsenic to enter the wafer interior, thereby changing the conductive properties of semiconductor materials to form different doping regions required for devices like transistors. The energy, dose, and beam uniformity of ion implantation equipment directly affect chip performance and manufacturing yield. SRI-I has gradually built relevant technical capabilities around high-energy ion implanters. The company has currently formed a product layout covering high-energy, medium-energy, high-current, and SiC-specific models, with applications spanning logic chips, memory chips, image sensors, and power semiconductors.
In terms of industrialization progress, the company launched high-energy ion implantation equipment in 2023 and subsequently advanced customer production line verification. In 2026, its SRII-8M high-energy ion implanter and SRII-60 high-current ion implanter were successively delivered to leading domestic integrated circuit customers, signaling that its product layout is beginning to extend from single models to different process scenarios. In terms of R&D, as of the end of June 2026, SRI-I had 232 R&D personnel, accounting for 29.37% of the total workforce. During the same period, the company had obtained 392 authorized patents, including 111 domestic patents, 281 overseas patents, and 355 invention patents, accounting for 90.56% of the total authorized patents.
03.Top Five Customers Accounted for 58.84% of Revenue in the First Half of This Year; Tsinghua and Peking Universities Are Also Clients
According to the prospectus, from 2023 to 2025, all of SRI-I's top five customers purchased ALD equipment. In the first half of 2026, as previously delivered ion implantation equipment passed customer verification, revenue recognition for ion implantation equipment began. Customer Q and Customer O entered the top five customers, ranking first and third, respectively. Meanwhile, the revenue share of the top five customers showed an overall upward trend, with increased customer concentration. The revenue share of the top five customers rose from 29.97% in 2023 to 58.84% in the first half of 2026.
It is worth noting that SRI-I's customers cover multiple well-known enterprises and research institutions in the semiconductor industry chain. Customers explicitly disclosed in the prospectus include Innoscience, BOE, Seeya Technology, Suzhou Enkris Semiconductor, Fuchuang Precision, as well as IMEC, the French Alternative Energies and Atomic Energy Commission (CEA), Peking University, Tsinghua University, and Massachusetts Institute of Technology (MIT). Raw materials procured by SRI-I mainly include mechanical, electronic and electrical, vacuum system, transmission system, fluid system, and instrumentation categories. Machined parts, sheet metal parts, power supplies and control modules, vacuum pumps, vacuum valves, as well as manipulators and wafer transfer systems, are all essential components for equipment production.
The procurement share of the top five suppliers decreased from 31.02% in 2023 to 18.22% in 2025, rebounding to 21.91% in the first half of 2026, but remained relatively dispersed overall. The prospectus states that SRI-I does not have any situation where procurement from a single supplier exceeds 50% of total procurement or severe dependence on a few suppliers.
Additionally, the prospectus disclosed enterprises that were both customers and suppliers during the reporting period, mainly including Fuchuang Precision and IMEC. SRI-I sells ALD equipment, spare parts, and technical services to Fuchuang Precision, primarily for its precision component coating processes; simultaneously, SRI-I purchases mechanical components required for equipment manufacturing from Fuchuang Precision. There exists both an equipment sales relationship and a component procurement relationship between the two parties. IMEC is a world-leading center for nanoelectronics and digital technology R&D and innovation. SRI-I sells ALD equipment, spare parts, and technical services to IMEC, primarily for scientific research activities; meanwhile, SRI-I also purchases industry alliance membership services and related training services from IMEC.
04.Chairman Holds Master's Degree from Tsinghua; No Controlling Shareholder
SRI-I was formerly known as Qingdao Sifang SRI Intelligent Technology Co., Ltd., established in January 2018 with an initial registered capital of CNY 300 million, jointly funded by shareholders Huayu Guohua and CRRC Qingdao Sifang Vehicle Research Institute.
The company's Chairman and General Manager, Nie Xiang, holds a Master of Business Administration degree from Tsinghua University. From July 2000 to December 2021, he worked at CRRC Sifang Institute, rising from Assistant Economist to Director; from January 2018 to December 2021, he joined SRI-I's management team as Director and General Manager; since December 2021, he has served as Chairman.
During each reporting period, the total pre-tax compensation (including equity payments) for SRI-I's directors, former supervisors during the reporting period, senior management, and core technical personnel was CNY 19.6822 million, CNY 24.4708 million, CNY 25.3257 million, and CNY 12.2063 million, respectively. The prospectus discloses multiple rounds of capital increase and equity transfers for SRI-I. Besides the initial two shareholders, other shareholders include employee stock ownership platforms such as Ruiyuan Junhe (with Chairman Nie Xiangwei as the actual controller), China Development Bank Transformation Fund, Huayu High-Tech, and Huayu Sci-Tech. SRI-I currently has no controlling shareholder or actual controller. Before issuance, CRRC Sifang Institute and Huayu Guohua held 16.15% and 15.30% stakes, respectively, making them the first and second largest shareholders.
05.Conclusion: Rising AI Computing Demand Brings New Opportunities for Domestic Semiconductor Equipment
Semiconductor equipment R&D features high investment, long cycles, and difficult customer verification. From breakthroughs in core technologies to production line verification and scaled delivery, it often requires sustained large-scale financial and R&D resource investment. As AI computing demand grows and capacity expands for advanced logic chips and high-bandwidth memory, demand for front-end equipment such as ALD thin film deposition and ion implantation will also rise. For SRI-I, the expansion of the AI chip and advanced memory industry chains brings new market space for its existing products and provides opportunities for further developing its high-end semiconductor equipment business.